Granahan Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

Granahan Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-74,047	Closed	-$1.21M	–	193
2020 Q1	$1.21M	Buy	74,047 +57,860	+357%	+$1.19M	0.07%	161
2019 Q4	$333K	Sell	16,187 -24,519	-60%	-$409K	0.02%	174
2019 Q3	$467K	Sell	40,706 -121,507	-75%	-$1.39M	0.03%	171
2019 Q2	$2.13M	Sell	162,213 -33,919	-17%	-$454K	0.11%	138
2019 Q1	$2.97M	Buy	196,132 +11,499	+6%	+$184K	0.16%	129
2018 Q4	$3.17M	Sell	184,633 -12,404	-6%	-$212K	0.22%	105
2018 Q3	$2.9M	Buy	197,037 +69,577	+55%	+$1.23M	0.16%	128
2018 Q2	$3.04M	Buy	127,460 +83,860	+192%	+$2.06M	0.18%	132
2018 Q1	$1.11M	Buy	+43,600	New	+$1.04M	0.08%	172

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Granahan Investment Management's COLL Position: Q2 2020 in Review

Granahan Investment Management sold out of Collegium Pharmaceutical (COLL) in Q2 2020, closing a stake of 74,047 shares — an estimated $1.21M sold.

Granahan Investment Management first reported a position in COLL in Q1 2018 and held it in 9 quarters. The position peaked at $3.17M in Q4 2018. 150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

Granahan Investment Management reported no remaining Collegium Pharmaceutical position as of Q2 2020 after selling out during the quarter.
Granahan Investment Management sold 74,047 Collegium Pharmaceutical shares in Q2 2020, an estimated $1.21M.
Granahan Investment Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 9 quarters.
Granahan Investment Management's Collegium Pharmaceutical position peaked at $3.17M in Q4 2018.
150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.